Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc., announced the acquisition of Cirrus Bio for an ...
Single-target agreement focused on development of novel, small molecule agonists of GPR52 discovered by Sosei Heptares with the potential to simultaneous...
Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selato...
"This new partnership builds on our innovation strategy and will allow us to explore the innovative approach of IL-21 blockage as a possible new pa...
Sequentify, a company specializing in DNA sequencing technology, has been granted funding by the Israel Innovation Authority (IIA). This grant, contr...
-DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Intelliseq, a genome informatics company and innovative provider of next-generation s...
This investment opportunity offers a unique chance for individuals and institutions to actively participate in the growth and transformation of the healthc...
Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new i...
ObvioHealth, a global digital clinical trials company delivering stronger clinical evidence through tech-enabled trials, has launched an innovative e...
Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in...
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...
New technologies in interventional cardiology further enhance the company’s comprehensive portfolio of cardiology solutions across the full c...
Trial expected to screen more than 1900 early-stage breast cancer patients at 120+ sites in 12 countries across Europe, commencing in...
“Traditionally, clients looking to purchase research models would review a static digital catalog, and follow-up with a phone call or email to our or...
© 2024 Biopharma Boardroom. All Rights Reserved.
